Skip to content

US Physical Therapy USPH Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Select Medical Holdings logo
Select Medical HoldingsSEM

Other financials

Income statement

See full
Revenue$198.3M+7.9%
Gross profit$32.8M+5.4%
Operating income$12.5M-36.5%
Net income$5.0M-49.1%
EPS (diluted)-$0.12-115%

Balance sheet

See full
Cash & equivalents$28.4M-27.4%
Total debt$169.4M+12.6%
Total equity$469.0M-5.7%
Total assets$1.2B+5.3%

Cash flow

See full
Operating cash flow$3.8M+181%
CapEx$5.4M+108%
Free cash flow-$1.6M+78.4%

Valuation

See full
Market cap$1.01B-10.6%
Enterprise value$1.15B-7.2%
P/E29×-4.8×
P/S1.3×-0.3×

Profitability

See full
Gross margin19%+0.9pp
Operating margin10%+0.3pp
Net margin4.4%-0.4pp
FCF margin8.4%+0.4pp

Returns & leverage

See full
Return on equity7.2%+0.4pp
Debt / equity0.4×+0.1×
Current ratio1.2×0.0×

Where this comes from

Reported directly by US Physical Therapy in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: US Physical Therapy’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about US Physical Therapy's equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is US Physical Therapy's equity in earnings (losses) of equity method investees?
US Physical Therapy (USPH) reported equity in earnings (losses) of equity method investees of $363K in Q1 2026.
How has US Physical Therapy's equity in earnings (losses) of equity method investees changed year-over-year?
US Physical Therapy's equity in earnings (losses) of equity method investees decreased by 7.6% year-over-year, from $393K to $363K.
What is the long-term trend for US Physical Therapy's equity in earnings (losses) of equity method investees?
Over 4 years (2021 to 2025), US Physical Therapy's equity in earnings (losses) of equity method investees has grown at a 90.6% compound annual growth rate (CAGR), from $112K to $1.48M.